Idera Pharmaceuticals to Present at BIO CEO Conference February 14th, 2012

CAMBRIDGE, Mass.--(BUSINESS WIRE)--Idera Pharmaceuticals (Nasdaq: IDRA) today announced that Sudhir Agrawal, D.Phil., Chairman and Chief Executive Officer, is scheduled to present at the 14th Annual BIO CEO & Investor Conference on February 13th at 10:30 am ET. Dr. Agrawal will provide a review of Idera's Toll-like Receptor-targeted development programs in oncology and autoimmune diseases as well as its gene silencing oligonucleotide (GSO) technology. The live webcast of the presentation wil

Feed Date: 
February 6, 2012